ORIC

NASDAQ HEALTHCARE

Oric Pharmaceuticals Inc

$8.50

-$0.50 (-5.56%)

Live quote

52w: $7.23 – $14.68

Loading chart…

P/E Ratio—

P/B Ratio2.45

EV/EBITDA—

Debt/Equity—

ROE-33.96%

ROIC—

Revenue Growth—

Gross Margin—

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of cancers. The company is headquartered in South San Francisco, California.

Own ORIC? Track it here.

Create a free account to add ORIC to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account